Ashfaq Ur Rehman

University of California, Irvine — United States

Chemistry · Physical Sciences

34h-index4.5kcitations158works10.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Synthesis and biological activity(30), Computational Drug Discovery Methods(21), Natural Antidiabetic Agents Studies(17), Synthesis and Characterization of Heterocyclic Compounds(16), Enzyme Production and Characterization(12)

Publications157 total

The Path Towards Effective Long-Lasting Tissue-Targeted Prime/Pull/Keep Herpes Simplex Therapeutic Vaccines
Vaccines·2025· 3 citedOpen Access
Comparative Analysis of “The Hunger Artist” by Franz Kafka and “The Happy Prince” by Oscar Wilde: Postmodernist Perspective
Journal of Asian Development Studies·2025Open Access
EXPLORING TARIQ RAHMAN’S ‘FRENEMIES’ THROUGH LEECH AND SHORT’S FRAMEWORK OF NARRATIVE VIEWPOINT: A STYLISTIC ANALYSIS
Journal for Current Sign·2025
Deciphering the structural and dynamic effects of SHP2-E76 mutations: mechanistic insights into oncogenic activation
BMC Chemistry·2025Open Access
Comparing the Effect of Volume-controlled Ventilation and Synchronized Intermittent Mandatory Ventilation on Respiratory Parameters of Traumatic Brain Injury Patients
Indus journal of bioscience research.·2025Open Access
Design and Biophysical Characterization of Second-Generation cyclic peptide LAG-3 inhibitors for cancer immunotherapy
Bioorganic & Medicinal Chemistry Letters·2024· 1 cited
Design and Biophysical Characterization of Second-Generation Cyclic Peptide LAG-3 Inhibitors for Cancer Immunotherapy
2024Open Access
Targeting SHP2 Cryptic Allosteric Sites for Effective Cancer Therapy
International Journal of Molecular Sciences·2024· 1 citedOpen Access
Role of artificial intelligence in revolutionizing drug discovery
Fundamental Research·2024· 102 citedOpen Access
Targeting SHP2 Cryptic Allosteric Sites for Effective Cancer Therapy
2024· 1 citedOpen Access
Targeting SHP2 Cryptic Allosteric Sites for Effective Cancer Therapy
2024· 3 citedOpen Access
CCDC 2161944: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
CCDC 2161948: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
CCDC 2161947: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
CCDC 2161946: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
CCDC 2161945: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
CCDC 2161943: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
CCDC 2214140: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
A novel alpha‐amylase inhibitor‐based <scp>spirooxindole‐pyrrolidine</scp>‐clubbed <scp>thiochromene‐pyrzaole</scp> pharmacophores: Unveiling the [3+2] cycloaddition reaction by molecular electron density theory
Chemical Biology & Drug Design·2023· 12 citedOpen Access
Discovering phenoxy acetohydrazide derivatives as urease inhibitors and molecular docking studies
Journal of Biomolecular Structure and Dynamics·2023· 6 cited
page 1 of 8Next →

Frequent Co-authors

Abdul Wadood(31), Muhammad Taha(15), Fazal Rahim(9), Haifeng Chen(8), Khalid Mohammed Khan(7), Jian Zhang(6), Sridevi Chigurupati(6), Khalid Mohammed Khan(6), Jiayi Li(6), Shaoyong Lu(5), Hayat Ullah(5), Abbas Khan(5), Dong‐Qing Wei(5), Rafaila Rafique(5), Uzma Salar(5), Hao Liu(5), Syed Shujait Ali(4), Yasir Ali(4), Shehryar Hameed(4), Mueed Ur Rahman(4)